Stock Market News

4 weeks Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of “Moderate Buy” by AnalystsMarketBeat

Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been given an average rating of “Moderate Buy” by the nine research firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rate…

Nasdaq 100 · Pharmaceuticals · Science

3 hours Equinix, Inc. (EQIX) Price Target Raised to $975 by Argus on Strong Growth Prospects and Positive MomentumInsider Monkey X

3 hours Advanced Micro Devices, Inc. (AMD) Set to Expand AI Portfolio with Affordable Krackan Point Processor LeakInsider Monkey X

3 hours Meta Platforms, Inc. (META) Advances Plans for $10 Billion AI Data Center in LouisianaInsider Monkey X

5 hours Amazon.com, Inc. (AMZN) Faces Potential EU Antitrust Investigation Over Marketplace Practices, Could Face Hefty FinesInsider Monkey X

5 hours Microsoft Corporation (MSFT) Unveils New AI Products and Features at Ignite, CEO Satya Nadella Highlights Rapid AI Investment GrowthInsider Monkey X

5 hours Alphabet Inc. (GOOG) Partners with Rezolve AI to Enhance Conversational Commerce SolutionsInsider Monkey X

5 hours Cadence (CDNS) Unveils First Arm-Based Chiplet: Boosting AI Efficiency and PowerInsider Monkey X

5 hours Fortinet, Inc (FTNT) and Skylark Launch AI-Powered Cybersecurity Centre in ChennaiInsider Monkey X

5 hours GlobalFoundries (GFS) Faces Market Oversupply: UBS Initiates Neutral RatingInsider Monkey X

5 hours QUALCOMM Incorporated (QCOM) CEO Cristiano Amon Dismisses Rumors of Intel Acquisition Amid AI Expansion into Cars and IoTInsider Monkey X

5 hours NVIDIA Corporation (NVDA) Beats Expectations with 70% YoY Revenue Growth and Strong AI Enterprise Demand, Citi Analyst SaysInsider Monkey X

6 hours FIFA, Mythical Games collaborate to launch blockchain game FIFA RivalsCointelegraph X

8 hours Lucid Is Shifting Into Higher Gear. Is the Stock a Buy Now?The Motley Fool X

8 hours 3 Dividend Stocks to Double Up on Right NowThe Motley Fool X

8 hours This Might Just Be Rivian’s Best Decision YetThe Motley Fool X

9 hours Is CrowdStrike Holdings a Buy?The Motley Fool X

10 hours Is Buying Airbnb Stock Below $135 a Smart Idea?The Motley Fool X

10 hours Can Anything Stop Nvidia?The Motley Fool X

10 hours Could Buying Apple Stock Today Set You Up for Life?The Motley Fool X

13 hours Should You Buy PayPal Stock While It’s Below $87?The Motley Fool X

13 hours Should You Buy PayPal Stock While It’s Below $87?The Motley Fool X

14 hours Got $1,500? Buy Iovance Biotherapeutics Now and Don’t Look BackThe Motley Fool X

14 hours Got $1,500? Buy Iovance Biotherapeutics Now and Don’t Look BackThe Motley Fool X

15 hours Supermicro Shares Soar as It Looks to Avoid Being Delisted. Is Now a Good Time to Buy the Beaten-Down Stock?The Motley Fool X

15 hours Supermicro Shares Soar as It Looks to Avoid Being Delisted. Is Now a Good Time to Buy the Beaten-Down Stock?The Motley Fool X

15 hours Advanced Micro Devices, Inc. (AMD) CEO Lisa Su Advocates for Open-Source AI Ecosystem and Holistic Data Center Design in IndiaInsider Monkey X

15 hours This 1 Investing Rule From Warren Buffett Could Supercharge (or Sink) Your PortfolioThe Motley Fool X

15 hours This 1 Investing Rule From Warren Buffett Could Supercharge (or Sink) Your PortfolioThe Motley Fool X

15 hours Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

15 hours Merus NV (MRUS): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

15 hours Nvidia Stock Investors Can Expect Revenue and Profit to Rise FurtherThe Motley Fool X

15 hours Nvidia Stock Investors Can Expect Revenue and Profit to Rise FurtherThe Motley Fool X

15 hours Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

15 hours Moderna Inc. (MRNA): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

16 hours Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

16 hours Guardant Health, Inc. (GH): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

16 hours Tango Therapeutics Inc. (TNGX): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

16 hours So Many Days Lost at the Doctor’s OfficeThe New York Times X

16 hours Immunitybio Inc. (IBRX): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

16 hours AstraZeneca (AZN): A Top Pick for Hedge Funds Due to Innovation and Rising DemandInsider Monkey X

16 hours ON Semiconductor (ON) Initiated at Overweight by Wells Fargo with $85 Target, Highlighting Gen-AI and EV Growth OpportunitiesInsider Monkey X

16 hours Arm Holdings (ARM) Set for Growth as Wells Fargo Targets $155 with Overweight RatingInsider Monkey X

16 hours Clean Energy Fuels Corp. (CLNE): Analysts Are Bullish On This Oil and Gas Stock NowInsider Monkey X

16 hours Trump Is Going To Turn Penny Stock EV Maker Lucid (LCID) Into a Donut24/7 Wall St. X

16 hours Super Micro (SMCI) Faces Nasdaq Delisting Risk: Compliance Plan in MotionInsider Monkey X

16 hours Intel (INTC) Replaced by NVIDIA on Dow Jones, Marking Shift in Semiconductor Industry LeadershipInsider Monkey X

16 hours Mark Zuckerberg’s Net Worth Nears $200 Billion24/7 Wall St. X

16 hours Nvidia Earnings Impress Again: Is It Safe for New Investors to Buy Nvidia Stock?The Motley Fool X

16 hours Nvidia Earnings Impress Again: Is It Safe for New Investors to Buy Nvidia Stock?The Motley Fool X

16 hours QUALCOMM Incorporated (QCOM) Expands Beyond Handsets: Bank of America’s Positive OutlookInsider Monkey X